CHST7 and non-small cell lung carcinoma: In this regard, possible application of the serum CHST7 concentration in differentiation of non-malignant pulmonary inflammations and non-small cell lung carcinoma (NSCLC) has been shown (N = 125, AUC = 0.85, sensitivity = 78%, specificity = 75%) (73).